tiprankstipranks
Trending News
More News >
Tectonic Therapeutic (TECX)
NASDAQ:TECX
US Market
Advertisement

Tectonic Therapeutic (TECX) Stock Statistics & Valuation Metrics

Compare
550 Followers

Total Valuation

Tectonic Therapeutic has a market cap or net worth of $478.47M. The enterprise value is $85.73M.
Market Cap$478.47M
Enterprise Value$85.73M

Share Statistics

Tectonic Therapeutic has 18,712,128 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,712,128
Owned by Insiders41.35%
Owned by Institutions24.23%

Financial Efficiency

Tectonic Therapeutic’s return on equity (ROE) is -0.41 and return on invested capital (ROIC) is -39.50%.
Return on Equity (ROE)-0.41
Return on Assets (ROA)-0.38
Return on Invested Capital (ROIC)-39.50%
Return on Capital Employed (ROCE)-0.41
Revenue Per Employee0.00
Profits Per Employee-1.14M
Employee Count51
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Tectonic Therapeutic is ―. Tectonic Therapeutic’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value2.78
Price to FCF
Price to Operating Cash Flow-6.42
PEG Ratio

Income Statement

In the last 12 months, Tectonic Therapeutic had revenue of 0.00 and earned -57.98M in profits. Earnings per share was -6.83.
Revenue0.00
Gross Profit-1.65M
Operating Income-58.02M
Pretax Income-57.98M
Net Income-57.98M
EBITDA-56.23M
Earnings Per Share (EPS)-6.83

Cash Flow

In the last 12 months, operating cash flow was -64.23M and capital expenditures -210.00K, giving a free cash flow of -64.44M billion.
Operating Cash Flow-64.23M
Free Cash Flow-64.44M
Free Cash Flow per Share-3.44

Dividends & Yields

Tectonic Therapeutic pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.34
52-Week Price Change33.18%
50-Day Moving Average22.29
200-Day Moving Average29.29
Relative Strength Index (RSI)58.02
Average Volume (3m)198.62K

Important Dates

Tectonic Therapeutic upcoming earnings date is Nov 6, 2025, TBA (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date

Financial Position

Tectonic Therapeutic as a current ratio of 12.65, with Debt / Equity ratio of 0.68%
Current Ratio12.65
Quick Ratio12.65
Debt to Market Cap<0.01
Net Debt to EBITDA2.45
Interest Coverage Ratio-542.20

Taxes

In the past 12 months, Tectonic Therapeutic has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Tectonic Therapeutic EV to EBITDA ratio is -4.52, with an EV/FCF ratio of -4.29.
EV to Sales0.00
EV to EBITDA-4.52
EV to Free Cash Flow-4.29
EV to Operating Cash Flow-4.30

Balance Sheet

Tectonic Therapeutic has $287.38M in cash and marketable securities with $1.94M in debt, giving a net cash position of -$285.44M billion.
Cash & Marketable Securities$287.38M
Total Debt$1.94M
Net Cash-$285.44M
Net Cash Per Share-$15.25
Tangible Book Value Per Share$16.58

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Tectonic Therapeutic is $83.60, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$83.60
Price Target Upside226.95% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast
EPS Growth Forecast71.85%

Scores

Smart Score7
AI Score42.25
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis